A Phase 1B Study of the Safety and Pharmacokinetics of Ritonavir-Boosted Elvitegravir (GS-9137/r) Plus a Background Regimen (BR) in HIV-1 Infected, Antiretroviral Treatment-Experienced Adolescents

Update Il y a 5 ans
Reference: EUCTR2008-003917-29

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the steady-state pharmacokinetics (PK) and confirm the dose of ritonavirboosted elvitegravir (GS-9137/r) in HIV-1 infected antiretroviral treatment-experienced adolescent subjects.


Inclusion criteria

  • Human Innunodeficiency Virus (HIV-1) Infections

Links